The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage
Open accessAbstract
The clinical diagnosis of Alzheimer's disease (AD) does not exactly match the pathological findings at autopsy in every subject. Therefore, in-vivo imaging measures, such as Magnetic Resonance Imaging (MRI) that reflect underlying pathology, would be clinically useful independent supplementary measures of disease stage. We have developed an algorithm that extracts atrophy information from individual patient's 3D MRI scans and assigns a STructural Abnormality iNDex (STAND)-score to the scan based on the degree of atrophy in comparison to patterns extracted from a large library of clinically well characterized AD and CN (cognitively normal) subject's MRI scans. STAND-scores can be adjusted for demographics to give adjusted-STAND (aSTAND)-scores which are >0 for subjects with brains identified as abnormal by the algorithm. Since histopathological findings are considered to represent the "ground truth", our objective was to assess the sensitivity of aSTAND-scores to pathological AD staging. This was done by comparing antemortem MRI based aSTAND-scores with postmortem grading of disease severity in 101 subjects who had both antemortem MRI and postmortem Braak neurofibrillary tangle (NFT) staging. We found a rank correlation of 0.62 (p<0.0001) between Braak NFT stage and aSTAND-scores. The results show that optimally extracted information from MRI scans such as STAND-scores accurately capture the severity of neuronal pathology and can be used as an independent approximate surrogate marker for in-vivo pathological staging as well as for early identification of AD in individual subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As well as revealing signs of atrophy, which can inform differential diagnosis of the disease, antemortem MRI has previously been found to correlate well with measures of cognitive deterioration and post-mortem Braak staging of the disease (Csernansky et al., 2004, Jack et al., 2002, Vemuri et al., 2008, Whitwell et al., 2008).”
From In vivo imaging of tau pathology using multi-parametric quantitative MRI (2015) · cites this paper as Vemuri et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Self-citationVoxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Self-citationAshburner, J., & Friston, K. J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.018 · Cited by 7,507
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Cited by
Sorted by citations
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Self-citationThe clinical use of structural MRI in Alzheimer disease
Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P., & Thompson, P. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.215 · Cited by 2,113
Self-citationRevising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Self-citationBiomarker Modeling of Alzheimer’s Disease
Jack, C. R., & Holtzman, D. M. (2013) · Neuron · doi:10.1016/j.neuron.2013.12.003 · Cited by 1,002
Self-citationBuilding better biomarkers: brain models in translational neuroimaging
Woo, C.-W., Chang, L. J., Lindquist, M. A., & Wager, T. D. (2017) · Nature Neuroscience · doi:10.1038/nn.4478 · Cited by 1,056
Brain atrophy in Alzheimer’s Disease and aging
Pini, L., Pievani, M., Bocchetta, M., Altomare, D., Bosco, P., Cavedo, E., Galluzzi, S., Marizzoni, M., & Frisoni, G. B. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.002 · Cited by 836
Jack, C. R., Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22628 · Cited by 602
Self-citationJack, C. R., Wiste, H. J., Vemuri, P., Weigand, S. D., Senjem, M. L., Zeng, G., Bernstein, M. A., Gunter, J. L., Pankratz, V. S., Aisen, P. S., et al. (2010) · Brain · doi:10.1093/brain/awq277 · Cited by 531
Self-citationBrain β-amyloid load approaches a plateau
Jack, C. R., Wiste, H. J., Lesnick, T. G., Weigand, S. D., Knopman, D. S., Vemuri, P., Pankratz, V. S., Senjem, M. L., Gunter, J. L., Mielke, M. M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840bbe · Cited by 406
Self-citationMRI and CSF biomarkers in normal, MCI, and AD subjects
Vemuri, P., Wiste, H. J., Weigand, S. D., Shaw, L. M. J., Trojanowski, J. Q., Weiner, M. W., Knopman, D. S., Petersen, R. C., & Jack, C. R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181af79fb · Cited by 406
Self-citationPathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Tryphena, K. P., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 438
Curtis, C., Gamez, J. E., Singh, U., Sadowsky, C. H., Villena, T., Sabbagh, M. N., Beach, T. G., Duara, R., Fleisher, A. S., Frey, K. A., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4144 · Cited by 332
Amyloid‐β associated cortical thinning in clinically normal elderly
Becker, J. A., Hedden, T., Carmasin, J., Maye, J., Rentz, D. M., Putcha, D., Fischl, B., Greve, D. N., Marshall, G. A., Salloway, S., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22333 · Cited by 342
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
Schmitz, T. W., Spreng, R. N., Initiative, T. A. D. N., Weiner, M. W., Aisen, P. S. S., Petersen, R. C., Jack, C. R., Jagust, W. J., Trojanowki, J. Q., Toga, A. W., et al. (2016) · Nature Communications · doi:10.1038/ncomms13249 · Cited by 345
Self-citationWidespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia
Lowe, V. J., Wiste, H. J., Senjem, M. L., Weigand, S. D., Therneau, T. M., Boeve, B. F., Josephs, K. A., Fang, P., Pandey, M. K., Murray, M. E., et al. (2017) · Brain · doi:10.1093/brain/awx320 · Cited by 311
Self-citationWang, L. Y., Benzinger, T. L. S., Su, Y., Christensen, J. J., Friedrichsen, K. A., Aldea, P., McConathy, J., Cairns, N. J., Fagan, A. M., Morris, J. C., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2078 · Cited by 301
Diagnostic neuroimaging across diseases
Klöppel, S., Abdulkadir, A., Jack, C. R., Koutsouleris, N., Mourão-Miranda, J., & Vemuri, P. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.002 · Cited by 279
Self-citationEskildsen, S. F., Coupé, P., García-Lorenzo, D., Fonov, V., Pruessner, J. C., & Collins, D. L. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.09.058 · Cited by 269
Mild cognitive impairment due to Alzheimer disease in the community
Petersen, R. C., Aisen, P., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Knopman, D. S., Mielke, M., Pankratz, V. S., Roberts, R., Rocca, W. A., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23931 · Cited by 265
Self-citationJack, C. R., Wiste, H. J., Weigand, S. D., Knopman, D. S., Mielke, M. M., Vemuri, P., Lowe, V. J., Senjem, M. L., Gunter, J. L., Reyes, D. A., et al. (2015) · Brain · doi:10.1093/brain/awv283 · Cited by 258
Self-citationMRI and CSF biomarkers in normal, MCI, and AD subjects
Vemuri, P., Wiste, H. J., Weigand, S. D., Shaw, L. M. J., Trojanowski, J. Q., Weiner, M. W., Knopman, D. S., Petersen, R. C., & Jack, C. R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181af79e5 · Cited by 251
Self-citationSex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans
Hua, X., Hibar, D. P., Lee, S., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.033 · Cited by 234
Self-citationThurfjell, L., Lilja, J., Lundqvist, R., Buckley, C. J., Smith, A. P. L., Vandenberghe, R. R., & Sherwin, P. F. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.142109 · Cited by 225
Evidence for Ordering of Alzheimer Disease Biomarkers
Jack, C. R. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.183 · Cited by 225
Self-citationAlzheimer disease: new concepts on its neurobiology and the clinical role imaging will play
Jack, C. R. (2012) · Radiology · doi:10.1148/radiol.12110433 · Cited by 211
Self-citationEffect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease
Vemuri, P., Wiste, H. J., Weigand, S. D., Knopman, D. S., Shaw, L. M., Trojanowski, J. Q., Aisen, P. S., Weiner, M., Petersen, R. C., Jack, C. R., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21953 · Cited by 195
Self-citationDiffusion tensor imaging and cognitive function in older adults with no dementia
Kantarci, K., Senjem, M. L., Avula, R., Zhang, B., Samikoglu, A. R., Weigand, S. D., Przybelski, S. A., Edmonson, H. A., Vemuri, P., Knopman, D. S., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31822313dc · Cited by 182
Self-citationToward a unified framework for interpreting machine-learning models in neuroimaging
Kohoutová, L., Heo, J., Cha, S., Lee, S., Moon, T., Wager, T. D., & Woo, C. (2020) · Nature Protocols · doi:10.1038/s41596-019-0289-5 · Cited by 176
Multimodality imaging characteristics of dementia with Lewy bodies
Kantarci, K., Lowe, V. J., Boeve, B. F., Weigand, S. D., Senjem, M. L., Przybelski, S. A., Dickson, D. W., Parisi, J. E., Knopman, D. S., Smith, G. E., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.024 · Cited by 178
Self-citationClinical prediction from structural brain MRI scans: A large-scale empirical study
Initiative, F. T. A. D. N., Sabuncu, M. R., & Konukoglu, E. (2015) · Neuroinformatics · doi:10.1007/s12021-014-9238-1 · Cited by 161
APOE modifies the association between Aβ load and cognition in cognitively normal older adults
Kantarci, K., Lowe, V. J., Przybelski, S. A., Weigand, S. D., Senjem, M. L., Ivnik, R. J., Preboske, G. M., Roberts, R. O., Geda, Y. E., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31824365ab · Cited by 168
Self-citation[18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy
Whitwell, J. L., Lowe, V. J., Tosakulwong, N., Weigand, S. D., Senjem, M. L., Schwarz, C. G., Spychalla, A. J., Petersen, R. C., Jack, C. R., & Josephs, K. A. (2017) · Movement Disorders · doi:10.1002/mds.26834 · Cited by 159
Self-citationPattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies
Nedelska, Z., Ferman, T. J., Boeve, B. F., Przybelski, S. A., Lesnick, T. G., Murray, M. E., Gunter, J. L., Senjem, M. L., Vemuri, P., Smith, G. E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.005 · Cited by 155
Self-citationGrothe, M. J., Teipel, S. J., & Initiative, F. T. A. D. N. (2016) · Human Brain Mapping · doi:10.1002/hbm.23018 · Cited by 150
Townley, R. A., Graff-Radford, J., Mantyh, W. G., Botha, H., Polsinelli, A. J., Przybelski, S. A., Machulda, M. M., Makhlouf, A. T., Senjem, M. L., Murray, M. E., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa068 · Cited by 145
Self-citationShapes of the Trajectories of 5 Major Biomarkers of Alzheimer Disease
Jack, C. R., Vemuri, P., Wiste, H. J., Weigand, S. D., Lesnick, T. G., Lowe, V., Kantarci, K., Bernstein, M. A., Senjem, M. L., Gunter, J. L., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.3405 · Cited by 145
Self-citationStructural imaging biomarkers of Alzheimer's disease: predicting disease progression
Eskildsen, S. F., Coupé, P., Fonov, V., Pruessner, J. C., & Collins, D. L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.034 · Cited by 129
Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration
Jack, C. R., Wiste, H. J., Knopman, D. S., Vemuri, P., Mielke, M. M., Weigand, S. D., Senjem, M. L., Gunter, J. L., Lowe, V. J., Gregg, B. E., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000386 · Cited by 129
Self-citationBiomarkers in Alzheimer's disease drug development
Cummings, J. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.06.004 · Cited by 122
Soares, H. D., Chen, Y., Sabbagh, M. N., Rohrer, A., Schrijvers, E. M. C., & Breteler, M. M. B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05066.x · Cited by 112
Physical exercise alleviates debilities of normal aging and Alzheimer’s disease
Archer, T. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01412.x · Cited by 112
Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND
Vemuri, P., Simon, G., Kantarci, K., Whitwell, J. L., Senjem, M. L., Przybelski, S. A., Gunter, J. L., Josephs, K. A., Knopman, D. S., Boeve, B. F., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.12.073 · Cited by 108
Self-citationTosun, D., Landau, S. M., Aisen, P. S. S., Petersen, R. C., Mintun, M. A., Jagust, W., Weiner, M. W., & Initiative, A. D. N. (2017) · Brain · doi:10.1093/brain/awx046 · Cited by 110
Self-citationBiomarkers in Sporadic and Familial Alzheimer’s Disease
Lista, S., O’Bryant, S. E., Blennow, K., Dubois, B., Hugon, J., Zetterberg, H., & Hampel, H. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143006 · Cited by 106
Carvalho, D. Z., Louis, E. K. S., Boeve, B. F., Mielke, M. M., Przybelski, S. A., Knopman, D. S., Machulda, M. M., Roberts, R. O., Geda, Y. E., Petersen, R. C., et al. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.08.023 · Cited by 110
Self-citationBrain structure and cognition 3 years after the end of an early menopausal hormone therapy trial
Kantarci, K., Tosakulwong, N., Lesnick, T. G., Zuk, S. M., Lowe, V. J., Fields, J. A., Gunter, J. L., Senjem, M. L., Settell, M. L., Gleason, C. E., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005325 · Cited by 104
Self-citationFocal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies
Kantarci, K., Ferman, T. J., Boeve, B. F., Weigand, S. D., Przybelski, S. A., Vemuri, P., Murray, M. E., Senjem, M. L., Smith, G. E., Knopman, D. S., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826357a5 · Cited by 102
Self-citationPost-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
Ikonomović, M. D., Buckley, C. J., Heurling, K., Sherwin, P. F., Jones, P. A., Zanette, M., Mathis, C. A., Klunk, W. E., Chakrabarty, A., Ironside, J. W., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0399-z · Cited by 102
In vivo imaging of tau pathology using multi-parametric quantitative MRI
Wells, J. A., O'Callaghan, J. M., Holmes, H. E., Powell, N. M., Johnson, R. A., Siow, B., Torrealdea, F., Ismail, O., Walker-Samuel, S., Golay, X., et al. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.02.023 · Cited by 93
Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease
Lowe, V. J., Lundt, E. S., Albertson, S. M., Przybelski, S. A., Senjem, M. L., Parisi, J. E., Kantarci, K., Boeve, B., Jones, D. T., Knopman, D., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.03.016 · Cited by 90
Self-citationQuantitative structural MRI for early detection of Alzheimer's disease
McEvoy, L. K., & Brewer, J. B. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.162 · Cited by 90
Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies
Sarro, L., Senjem, M. L., Lundt, E. S., Przybelski, S. A., Lesnick, T. G., Graff-Radford, J., Boeve, B. F., Lowe, V. J., Ferman, T. J., Knopman, D. S., et al. (2016) · Brain · doi:10.1093/brain/aww193 · Cited by 89
Self-citationSalloway, S., Gamez, J. E., Singh, U., Sadowsky, C. H., Villena, T., Sabbagh, M. N., Beach, T. G., Duara, R., Fleisher, A. S., Frey, K. A., et al. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.06.001 · Cited by 87
Selective Disruption of the Cerebral Neocortex in Alzheimer's Disease
Desikan, R. S., Sabuncu, M. R., Schmansky, N. J., Reuter, M., Cabral, H., Hess, C. P., Weiner, M. W., Biffi, A., Anderson, C. D., Rosand, J. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012853 · Cited by 83
Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI
Holland, D., McEvoy, L. K., Dale, A. M., & Initiative, T. A. D. N. (2011) · Human Brain Mapping · doi:10.1002/hbm.21386 · Cited by 85
Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer’s disease
Poulakis, K., Pereira, J. B., Muehlboeck, J., Wahlund, L., Smedby, Ö., Volpe, G., Masters, C. L., Ames, D. J., Niimi, Y., Iwatsubo, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32202-6 · Cited by 92
Hua, X., Lee, S., Hibar, D. P., Yanovsky, I., Leow, A., Toga, A. W., Jack, C. R., Bernstein, M. A., Reiman, E. M., Harvey, D. J., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.104 · Cited by 84
Self-citationSpatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease
Wang, L. Y., Benzinger, T. L. S., Hassenstab, J. J., Blazey, T., Owen, C., Liu, J., Fagan, A. M., Morris, J. C., & Ances, B. M. (2015) · Neurology · doi:10.1212/wnl.0000000000001401 · Cited by 79
A computational model of neurodegeneration in Alzheimer’s disease
Jones, D., Lowe, V., Graff-Radford, J., Botha, H., Barnard, L., Wiepert, D., Murphy, M. C., Murray, M., Senjem, M., Gunter, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29047-4 · Cited by 78
Self-citationApplying tensor-based morphometry to parametric surfaces can improve MRI-based disease diagnosis
Wang, Y., Yuan, L., Shi, J., Greve, A., Ye, J., Toga, A. W., Reiss, A. L., & Thompson, P. M. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.02.011 · Cited by 72
Magnetic resonance imaging of Huntington's disease: preparing for clinical trials
Klöppel, S., Henley, S. M. D., Hobbs, N. Z., Wolf, R. C., Kassubek, J., Tabrizi, S. J., & Frackowiak, R. S. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.045 · Cited by 71
Shi, J., Leporé, N., Gutman, B. A., Thompson, P. M., Baxter, L. C., Caselli, R. J., Wang, Y., & Initiative, A. D. N. (2014) · Human Brain Mapping · doi:10.1002/hbm.22447 · Cited by 74
Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials
Holland, D., McEvoy, L. K., Desikan, R. S., Dale, A. M., & Initiative, A. D. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047739 · Cited by 71
Neuroimaging in frontotemporal lobar degeneration—predicting molecular pathology
Whitwell, J. L., & Josephs, K. A. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.7 · Cited by 73
Self-citationImaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
Femminella, G. D., Thayanandan, T., Calsolaro, V., Komici, K., Rengo, G., Corbi, G., & Ferrara, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123702 · Cited by 74
Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study
Klöppel, S., Peter, J., Ludl, A., Pilatus, A., Maier, S., Mader, I., Heimbach, B., Frings, L., Egger, K., Dukart, J., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150334 · Cited by 69
Dallaire‐Théroux, C., Callahan, B. L., Potvin, O., Saïkali, S., & Duchesne, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161028 · Cited by 71
Advances in MRI Biomarkers for the Diagnosis of Alzheimer’s Disease
Kehoe, E. G., McNulty, J. P., Mullins, P. G., & Bokde, A. L. W. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.42 · Cited by 70
Alliance for aging research AD biomarkers work group: structural MRI
Jack, C. R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.011 · Cited by 64
Self-citationHänggi, J., Streffer, J. R., Jäncke, L., & Höck, C. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101260 · Cited by 64
Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia
Tetzloff, K. A., Duffy, J. R., Clark, H. M., Strand, E. A., Machulda, M. M., Schwarz, C. G., Senjem, M. L., Reid, R. I., Spychalla, A. J., Tosakulwong, N., et al. (2017) · Brain · doi:10.1093/brain/awx293 · Cited by 62
Self-citationA comparison of three brain atlases for MCI prediction
Ota, K., Oishi, N., Ito, K., & Fukuyama, H. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.10.003 · Cited by 61
Crescenzi, R. L., DeBrosse, C., Nanga, R. P. R., Byrne, M. D., Krishnamoorthy, G., D’Aquilla, K., Nath, H., Morales, K. H., Iba, M., Hariharan, H., et al. (2016) · Hippocampus · doi:10.1002/hipo.22693 · Cited by 60
Role of hippocampal CA1 atrophy in memory encoding deficits in amnestic Mild Cognitive Impairment
Fouquet, M., Desgranges, B., Joie, R. L., Rivière, D., Mangin, J., Landeau, B., Mézenge, F., Pèlerin, A., Sayette, V. D. L., Viader, F., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.036 · Cited by 56
Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers
Quiroz, Y. T., Stern, C. E., Reiman, E. M., Brickhouse, M. J., Ruiz‐Rizzo, A. L., Sperling, R. A., Lopera, F. J., & Dickerson, B. C. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303299 · Cited by 50
Shi, J., Stonnington, C. M., Thompson, P. M., Chen, K., Gutman, B. A., Reschke, C., Baxter, L. C., Reiman, E. M., Caselli, R. J., & Wang, Y. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.09.062 · Cited by 50
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
Adamczuk, K., Schaeverbeke, J. M., Vanderstichele, H., Lilja, J., Nelissen, N., Laere, K. V., Dupont, P. J., Hilven, K., Poesen, K., & Vandenberghe, R. R. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0159-5 · Cited by 49
Effects of age on the glucose metabolic changes in mild cognitive impairment
Kantarci, K., Senjem, M. L., Lowe, V. J., Wiste, H. J., Weigand, S. D., Kemp, B. J., Frank, A. R., Shiung, M. M., Boeve, B. F., Knopman, D. S., et al. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2070 · Cited by 47
Self-citationLeoni, V., & Caccia, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.03.015 · Cited by 48
Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?
Whitwell, J. L., Tosakulwong, N., Weigand, S. D., Senjem, M. L., Lowe, V. J., Gunter, J. L., Boeve, B. F., Knopman, D. S., Dickerson, B. C., Petersen, R. C., et al. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.01.006 · Cited by 47
Self-citationLeinonen, V., Rinne, J. O., Virtanen, K. A., Eskola, O., Rummukainen, J., Huttunen, J., zu Fraunberg, M. V. U., Nerg, O., Koivisto, A. M., Rinne, J., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12102 · Cited by 43
Clinical Diagnosis of Alzheimer’s Disease
Khan, T. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804832-0.00002-x · Cited by 46
Yu, P., Initiative, A. D. N., Dean, R. A., Hall, S. D., Qi, Y., Sethuraman, G., Willis, B. A., Siemers, E., Martényi, F., Tauscher, J. T., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120832 · Cited by 42
Bonifacio, G., & Zamboni, G. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133759 · Cited by 41
CSF beta‐amyloid 1–42 – what are we measuring in Alzheimer's disease?
Hu, W. T., Watts, K. D., Shaw, L. M. J., Howell, J. C., Trojanowski, J. Q., Basra, S. S., Glass, J. D., Lah, J. J., & Levey, A. I. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.160 · Cited by 38
The neurobiology of Alzheimer disease defined by neuroimaging
Masdeu, J. C., Kreisl, W. C., & Berman, K. F. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283557b36 · Cited by 39
Giulietti, G., Torso, M., Serra, L., Spanò, B., Marra, C., Caltagirone, C., Cercignani, M., Bozzali, M., & (ADNI), T. A. D. N. I. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25947 · Cited by 36
Using Structural and Diffusion Magnetic Resonance Imaging To Differentiate the Dementias
Suri, S., Topiwala, A., Mackay, C. E., Ebmeier, K. P., & Filippini, N. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0475-3 · Cited by 35
Using Biomarkers to Improve Detection of Alzheimer’s Disease
Biagioni, M. C., & Galvin, J. E. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.11 · Cited by 35
Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions
Archer, T., Kostrzewa, R. M., Beninger, R. J., & Palomo, T. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9190-2 · Cited by 34
Tracking the development of agrammatic aphasia: A tensor-based morphometry study
Whitwell, J. L., Duffy, J. R., Machulda, M. M., Clark, H. M., Strand, E. A., Senjem, M. L., Gunter, J. L., Spychalla, A. J., Petersen, R. C., Jack, C. R., et al. (2016) · Cortex · doi:10.1016/j.cortex.2016.09.017 · Cited by 31
Self-citationde Souza, L. C., Lehéricy, S., Dubois, B., Stella, F., & Sarazin, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328357b9ab · Cited by 28
Rates of lobar atrophy in asymptomatic MAPT mutation carriers
Chen, Q., Boeve, B. F., Senjem, M., Tosakulwong, N., Lesnick, T. G., Brushaber, D., Dheel, C., Fields, J., Forsberg, L., Gavrilova, R., et al. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.05.010 · Cited by 28
Self-citationRaj, A., Tora, V., Gao, X., Cho, H., Choi, J. Y., Ryu, Y. H., Lyoo, C. H., & Franchi, B. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0841 · Cited by 27
Posterior cortical atrophy phenotypic heterogeneity revealed by decoding 18F-FDG-PET
Townley, R. A., Botha, H., Graff‐Radford, J., Whitwell, J. L., Boeve, B. F., Machulda, M. M., Fields, J. A., Drubach, D. A., Savica, R., Petersen, R. C., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab182 · Cited by 25
Self-citationValkanova, V., & Ebmeier, K. P. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.02.016 · Cited by 27
Neuroanatomical correlates of phonologic errors in logopenic progressive aphasia
Petroi, D., Duffy, J. R., Borgert, A. J., Strand, E. A., Machulda, M. M., Senjem, M. L., Jack, C. R., Josephs, K. A., & Whitwell, J. L. (2020) · Brain and Language · doi:10.1016/j.bandl.2020.104773 · Cited by 23
Self-citationNeuroimaging in Neurodegenerative Dementias
McGinnis, S. M. (2013) · Seminars in Neurology · doi:10.1055/s-0032-1331808 · Cited by 23
Voxel-wise deviations from healthy aging for the detection of region-specific atrophy
Klöppel, S., Yang, S., Kellner, E., Reisert, M., Heimbach, B., Urbach, H., Linn, J., Weidauer, S., Andres, T., Bröse, M., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.09.013 · Cited by 21
Metadata
- Authors
- Vemuri, P., Whitwell, J. L., Kantarci, K., Josephs, K. A., Parisi, J. E., Shiung, M. S., Knopman, D. S., Boeve, B. F., Petersen, R. C., Dickson, D. W., & Jack, C. R.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Jack, Clifford R.
- ORCID
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 42
- Issue
- 2
- Pages
- 559-567
- ISSN
- 1053-8119 (ISSN-L)
- PMC
- PMC3097053
- OpenAlex
- W1990502495
- Cited by
- 172
- References
- 60
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 3 · 2022: 6 · 2021: 11 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 9 · 2016: 14 · 2015: 11 · 2014: 16 · 2013: 15 · 2012: 13
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- NeuroImage (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG11378, K23AG030935, P50‐AG16574, R01 AG06786, U01AG006786, R01AG011378, P50AG016574)
- National Center for Research Resources (KL2RR024151, K12RR24151, C06RR018898)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
- Keywords
- Alzheimer's disease, neurofibrillary tangles, Braak staging, brain atrophy, postmortem neuropathology, disease staging, early detection of Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Brain, Diagnosis, Female, Humans, Magnetic Resonance Imaging, Male, Sensitivity and Specificity, Severity of Illness Index, Statistics as Topic, Reproducibility of Results, Neurofibrillary Tangles, Imaging, Three-Dimensional
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
